# Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

> **NCT00700687** · PHASE1 · COMPLETED · sponsor: **POZEN** · enrollment: 90 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PA32540
- **DRUG:** PA32540 and celecoxib
- **DRUG:** aspirin and [NSAID]

## Key facts

- **NCT ID:** NCT00700687
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2009-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00700687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00700687, "Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00700687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*